Biotechnology company Biogen Inc. (BIIB) Friday announced its agreement to acquire Reata Pharmaceuticals, Inc. (RETA) for $172.50 per share in cash, reflecting an enterprise value of around $7.3 billion. In pre-market activity on Nasdaq, Reata shares were gaining around 15.2 percent to trade at $125, while Biogen shares were losing […]

» Read more

FLSmidth (FLIDF.PK), a Danish engineering company, Friday said its Cement unit sold its Advanced Filtration Technologies or AFT filter media business to Micronics, a provider of industrial filtration solutions. Further, the company raised its fiscal 2023 EBITDA margin and adjusted EBITDA margin view to reflect the expected net gain of […]

» Read more